Proton-pump inhibitor therapy and the development of dysplasia in patients with Barretts oesophagus
Objective: To examine whether proton-pump inhibitor (PPI) therapy influences the incidence and progression of dysplasia in patients with Barrett's oesophagus. Design and setting: Review of prospective data on patients undergoing surveillance with regular
|Collections||ANU Research Publications|
|Source:||Medical Journal of Australia|
|01_Hillman_Proton-pump_inhibitor_therapy_2004.pdf||132.14 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.